| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/25/2009 | US20090162835 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| 06/25/2009 | US20090162402 Immunizing compositions and methods of use |
| 06/25/2009 | US20090162383 Method for designing vaccines against constantly mutating pathogens |
| 06/25/2009 | US20090162354 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 06/25/2009 | US20090162336 Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease |
| 06/25/2009 | US20090162278 Method for Production of Radioisotope Preparations and Their Use in Life Science, Research, Medical Application and Industry |
| 06/25/2009 | DE102007063429A1 Production of reactive additives for use e.g. in binders or as biosurfactants, involves high-pressure thermolysis in aqueous medium in several stages with increases of temperature and pressure between stages |
| 06/25/2009 | CA2708836A1 Methods for purifying or depleting molecules or cells of interest |
| 06/25/2009 | CA2705439A1 Hypoallergenic cereal protein and uses thereof |
| 06/24/2009 | EP2072056A1 Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 06/24/2009 | EP1546090B1 Method for producing acylated peptides |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | CN101463073A Continuous extraction method for Jatrohpa curcas toxic protein |
| 06/24/2009 | CN101463072A Preparation of cholecystokinin octapeptide |
| 06/24/2009 | CN101463071A Preparation of flounder erythrocyte outer membrane protein |
| 06/24/2009 | CN101463070A Technology for solid phase synthesis of peptide by WANG strategy |
| 06/24/2009 | CN100503635C Crystal of human avidin protein and preparation thereof |
| 06/23/2009 | USRE40789 Mammalian checkpoint proteins polypeptides and encoding sequences thereof |
| 06/23/2009 | US7550567 Contaminating proteins are depleted by negative chromatography and/or negative adsorption using cation exchanger, hydrophobic gel and/or dye gel; improved stability; fibrin glue |
| 06/23/2009 | US7550566 G-CSF conjugates |
| 06/23/2009 | US7550565 G-CSF conjugates |
| 06/23/2009 | US7550563 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain |
| 06/23/2009 | US7550560 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 06/23/2009 | US7550558 Antimicrobial peptides and methods for identifying and using such peptides |
| 06/23/2009 | US7550431 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 06/23/2009 | US7550263 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 06/18/2009 | WO2009073975A1 Production of recombinant interferon proteins |
| 06/18/2009 | WO2009059082A3 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 06/18/2009 | WO2008073382A9 Hsp90 and ip6k2 binding |
| 06/18/2009 | WO2004039962A3 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 06/18/2009 | WO2004016745A3 Backterial effector proteins which inhibit programmed cell death |
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 06/18/2009 | US20090156485 Method for coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups |
| 06/18/2009 | US20090155293 Modified defensins and their use |
| 06/18/2009 | US20090151600 Adhesive protein extracted from Mytilus galloprovincialis, Mytilus galloprovincialis foot protein-5; can be used as medical adhesives as they are non-toxic to the human body and do not impose immunogenicity; water-resistant bioadhesives |
| 06/18/2009 | DE102007060599A1 Verfahren zur Extraktion von Membranproteinen A process for extracting membrane proteins |
| 06/17/2009 | EP2071024A1 Peptides of human prostatic acid phosphatase enhancing viral infectivity |
| 06/17/2009 | EP2070947A1 Therapeutic and diagnostic anti-Hsp70 antibodies |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2069486A2 Phytases with improved thermal stability |
| 06/17/2009 | EP2069387A1 Methods for purifying antibodies using ceramic hydroxyapatite |
| 06/17/2009 | EP2069386A2 Sharply resolving labeled protein molecular weight standards |
| 06/17/2009 | EP2069385A1 Membranous protein immobilisation on a carrier using an amphiphile molecule |
| 06/17/2009 | EP2069384A2 Biomarker fragments for the detection of human bnp |
| 06/17/2009 | EP2068629A2 Compositions and methods for treating cancer |
| 06/17/2009 | EP1745078B1 Method for the purification of albumin conjugates |
| 06/17/2009 | EP1668356B1 Method for controlling the treatment of a crystal by means of a liquid |
| 06/17/2009 | EP1648933B1 Long lasting insulin derivatives and methods thereof |
| 06/17/2009 | CN101456898A Method for separating and purifying polypeptide by using hydrogen bond adsorption chromatogram |
| 06/17/2009 | CN100500837C Methods for separating molecules |
| 06/17/2009 | CN100500692C Novel LHRH antagonists, preparation method and pharmaceutical use thereof |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547762 T24 antigen for immunodiagnosis of Taenia solium cysticercosis |
| 06/16/2009 | US7547761 For isolating low molecular weight peptides from animal tissue; prevention of initial dissolution of higher molecular weight fraction proteins by in situ denaturation within the tissue, by an organic solvent (preferably ethanol), prior to aqueous extraction |
| 06/16/2009 | US7547760 Using the anti-SHP2 peptides and SEBA compounds (4-(2-sulfaminoethyl)benzoic acid) reverses cell transformation and induces remission of preformed tumors in vivo demonstrating a possible treatment for cancer; phosphotyrosyl phosphatase |
| 06/16/2009 | US7547675 Chemically modified polypeptides |
| 06/16/2009 | US7547528 Expression vector comprising nucleotide sequences coding coral fluorescent protein for use as reporter molecules in genetic engineering |
| 06/16/2009 | CA2186858C Surface-modifying endgroups for biomedical polymers |
| 06/11/2009 | WO2009070883A1 Polymer synthesizer |
| 06/11/2009 | WO2009034190A3 Affinity tag |
| 06/11/2009 | WO2009003952A3 Column and method for preparing a biological sample for protein profiling |
| 06/11/2009 | WO2006078404A3 Notch1 variants associated with cardiovascular disease |
| 06/11/2009 | WO2006017171A3 Methods of diagnosing & treating obesity, diabetes and insulin resistance |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2001098458A3 Methods for immobilizing polypeptides |
| 06/11/2009 | US20090149638 Systems and methods for purifying proteins |
| 06/11/2009 | US20090149632 Antibacterial peptide |
| 06/11/2009 | US20090149630 Stabilized Alpha Helical Peptides and Uses Thereof |
| 06/11/2009 | US20090149628 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 06/11/2009 | US20090148952 Materials and methods for controlling isotope effects during fractionation of analytes |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148435 Antibody purification by cation exchange chromatography |
| 06/11/2009 | US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 06/11/2009 | US20090145203 Plugged flow 2d chromatography |
| 06/11/2009 | CA2746074A1 Polymer synthesizer |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066788A2 Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor |
| 06/10/2009 | EP2066428A1 Compositions and devices for electro-filtration of molecules |
| 06/10/2009 | EP2066419A1 Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
| 06/10/2009 | EP1409667B2 Process for preparing variant polynucleotides |
| 06/10/2009 | EP0711303B2 Biotinylation of proteins |
| 06/10/2009 | CN201254541Y Glutamic acid thalli protein flocculating separator |
| 06/10/2009 | CN101454336A Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress |
| 06/10/2009 | CN100497371C Process for producing plant concentration protein |
| 06/10/2009 | CN100497370C Bursopoietin extracting method and its use in disease treating and immune |
| 06/10/2009 | CN100497369C Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 06/09/2009 | US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 06/09/2009 | US7544784 The invention provides methods of increasing yields of desired conformation of proteins. In particular embodiments, the invention includes contacting preparations of a recombinant protein with a reduction/oxidation coupling reagent for a time sufficient to increase the relative proportion of a desired co |
| 06/09/2009 | US7544781 Polypeptide and process for producing the same |
| 06/09/2009 | US7544665 Synthesis using peptide intermediate fragments |
| 06/09/2009 | US7544638 Device for chemical and biochemical reactions using photo-generated reagents |
| 06/09/2009 | US7544493 Method for the purification of an N-terminal fragment of hepatocyte growth factor |
| 06/09/2009 | US7544486 transfecting a mammalian cell with nucleic acid construct to express bone growth factor; implants; inducing osteogenic differentiation, osteoblastic mineralization and/or bone formation in clinical applications; lower doses of each growth factor hence cheaper; for treating bone disorders |
| 06/09/2009 | US7544368 A scaffold of biodegradable biopolymers including a combination of either collagen or gelatin and either chondroitin-6-sulfate, chondrotin-4-sulfate, heparin, heparan sulfate, keratan sulfate, dermatan sulfate, chitin, or chitosan; tissue engineering; glaucoma; antiscarring agents; kits; druug-free |
| 06/09/2009 | US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 06/09/2009 | CA2225178C A process for isolating insulin by high-pressure liquid chromatography |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070558A1 Method for isolation of genomic dna, rna and proteins from a single sample |